|By PR Newswire||
|March 6, 2014 07:21 PM EST||
PHILADELPHIA, March 6, 2014 /PRNewswire/ -- Cohen, Placitella & Roth, PC is investigating claims on behalf of investors who purchased Galena Biopharma, Inc. ("Galena" or "Company") (NASDAQ: GALE) stock between November 6, 2013 and February 14, 2014, inclusive. The investigation concerns whether Galena disseminated materially false and/or misleading information to investors in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
Galena is a biotechnology company focused on the development and commercialization of targeted oncology treatments that address major unmet medical needs to advance cancer care. On February 12, 2014, an article on TheStreet.com disclosed that Galena was engaging in a misleading brand awareness campaign aimed at boosting its stock price. Additionally, the article represented that Galena paid investor relations firm The DreamTeam Group ("DreamTeam") to publish articles under aliases promoting the Company's stock without disclosing who paid for them. On this news, Galena's stock price dropped $0.85 per share to close at $4.34 per share on February 12, 2014, a one-day decline of 16% on volume of nearly 24 million shares. Then, on February 14, 2014, Galena issued a letter to its shareholders acknowledging that the Company had engaged DreamTeam. On this news, Galena's stock price dropped another $0.63 per share to close at $3.73 per share on February 14, 2014, a one-day decline of 14% on volume of nearly 41 million shares, and a decline of 50% from the stock's Class Period high.
If you have any information on Galena's surreptitious and improper touting of its own stock or you wish to consider serving as lead plaintiff, please contact Eduardo A. Texidor, Jr., no later than May 5, 2014, at [email protected] or, toll free, at 1-888-375-7600. For those investors inquiring via email, please be sure to include "Galena Biopharma" in the subject line, the number of shares purchased, and your mailing address and telephone number.
Since 1973, Cohen, Placitella & Roth, PC has been recognized as one of the premier trial law firms in the country. The firm has extensive experience in prosecuting securities litigation involving violations of the federal securities laws, state law derivative actions and mergers and acquisitions cases, representing institutional investors such as public pension plans and union pension funds as well as individual shareholders suffering substantial investment losses due to corporate misconduct. LexisNexis Martindale-Hubbell® annually reports Cohen, Placitella & Roth's peer rating-the highest AV® - "a testament to professional excellence." Since the inauguration of its "Best Law Firms"' edition in 2010, U.S. News and World Report has annually listed Cohen, Placitella & Roth's as one of the top-tier class action law firms in the country.
SOURCE Cohen, Placitella & Roth, PC
Dec. 5, 2016 07:45 PM EST Reads: 2,208
Dec. 5, 2016 07:45 PM EST Reads: 2,077
Dec. 5, 2016 07:15 PM EST Reads: 347
Dec. 5, 2016 07:15 PM EST Reads: 2,049
Dec. 5, 2016 07:15 PM EST Reads: 5,033
Dec. 5, 2016 07:00 PM EST Reads: 1,840
Dec. 5, 2016 07:00 PM EST Reads: 1,806
Dec. 5, 2016 06:15 PM EST Reads: 1,549
Dec. 5, 2016 05:45 PM EST Reads: 1,593
Dec. 5, 2016 05:15 PM EST Reads: 1,686
Dec. 5, 2016 04:30 PM EST Reads: 2,051
Dec. 5, 2016 04:30 PM EST Reads: 872
Dec. 5, 2016 04:15 PM EST Reads: 858
Dec. 5, 2016 04:00 PM EST Reads: 2,552
Whether your IoT service is connecting cars, homes, appliances, wearable, cameras or other devices, one question hangs in the balance – how do you actually make money from this service? The ability to turn your IoT service into profit requires the ability to create a monetization strategy that is flexible, scalable and working for you in real-time. It must be a transparent, smoothly implemented strategy that all stakeholders – from customers to the board – will be able to understand and comprehe...
Dec. 5, 2016 03:45 PM EST Reads: 342